Thomas W. Flaig
- Pulmonary and Respiratory Medicine top 0.2%
- Oncology top 1%
- Molecular Biology top 5%
- Cancer Research top 1%
- Surgery top 2%
- Co-authors
- Fred SaadKarim FizaziJohann S. de BonoNeal D. ShoreHoward I. ScherAndrew J. ArmstrongCora N. SternbergPaul N. Mainwaring
- Topics
- Bladder and Urothelial Cancer Treatments (83 papers)Prostate Cancer Treatment and Research (70 papers)Urinary and Genital Oncology Studies (46 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Thomas W. Flaig
198 papers receiving 7.8k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Pulmonary and Respiratory Medicine 5.2k
- Oncology 2.3k
- Molecular Biology 2.1k
- Cancer Research 1.7k
- Surgery 1.6k
Countries citing papers authored by Thomas W. Flaig
This map shows the geographic impact of Thomas W. Flaig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas W. Flaig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas W. Flaig more than expected).
Fields of papers citing papers by Thomas W. Flaig
This network shows the impact of papers produced by Thomas W. Flaig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas W. Flaig. The network helps show where Thomas W. Flaig may publish in the future.
Co-authorship network of co-authors of Thomas W. Flaig
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas W. Flaig. A scholar is included among the top collaborators of Thomas W. Flaig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas W. Flaig. Thomas W. Flaig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 7 | |
| 5 | 1 | |
| 6 | 0 | |
| 7 | 1 | |
| 8 | 2 | |
| 9 | 3 | |
| 10 | 3 | |
| 11 | Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancerbreakdown → | 163 |
| 12 | 7 | |
| 13 | 58 | |
| 14 | 32 | |
| 15 | 1 | |
| 16 | EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4–Positive Solid Tumors, Including Metastatic Urothelial Carcinomabreakdown → | 223 |
| 17 | 183 | |
| 18 | 13 | |
| 19 | 10 | |
| 20 | 25 |
About Thomas W. Flaig
Thomas W. Flaig is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 209 papers that have together received 7.9k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (83 papers), Prostate Cancer Treatment and Research (70 papers) and Urinary and Genital Oncology Studies (46 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (5.2k citations), Cancer Research (1.7k citations) and Oncology (2.3k citations). Thomas W. Flaig has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Fred Saad, Karim Fizazi, Johann S. de Bono, Neal D. Shore, Howard I. Scher, Andrew J. Armstrong, Cora N. Sternberg, Paul N. Mainwaring, Bryan Selby and Ronald de Wit. Their work appears in journals such as New England Journal of Medicine, Advanced Materials and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.